What is driving the demand for Bioprocess Technology Market?
Key drivers that exist in the field of bioprocess technology. The swift progress of this field can be accounted to the evolution of biopharmaceuticals and biotechnology industries.
Due to the rapid increase in the demand for new drugs in the market which initiates the demand for producing new drugs, the bioprocess technology is needed to fulfil this increasing demand. The increasing prevalence of chronic diseases is also one of the main factors driving the demand for bioprocess technology.
In recent years, the importance of research and development in the life sciences industry has been strongly promoted. With this trend, government support for the pharmaceutical and biotech industries is also increasing.
The other fast-growing field in bioprocess technology is oligosaccharide manufacturing. Due to their many health benefits in treating chronic diseases, they have several promising uses and applications in the food industry. These effects have led to a surge in market demand.
What are the technological advances opportunities in bioprocess technology?
The recent advances in cell-based bioprocessing has led the manufacturers to attain an improved ability to turn out bio therapeutics such as bi- and tri-specific antibodies, novel vaccines and many others.
This paradigm shift and the digital transformation of the bio fabrication process will lead to a future facility that truly becomes an ecosystem that seamlessly integrates seamless, connected, and enhanced processing with seamless data collection and analysis. In short, this will enable real-time batch release and unattended manufacturing, bringing maximum benefits to patients around the world and expanding access to affordable and readily available life-saving and life-enhancing biological therapies.
Know More Details About the Report
Bioprocess technology demand: Regional outlook.
The strong growth of the North American market was triggered by the strong demand for high-quality biological agents and the high emphasis on R&D by well-known companies in the region. The bioprocess technology market in the region may be driven by the expansion of the biopharmaceutical industry, the increase in government initiatives, the development of research and development, the increase in investment from major market players, and the trend of outsourcing production to Asia-Pacific countries full of cheap products, high-skilled labour force.
In the European market, significant increase in the demand and use of Single- Use technology (SUT) has led to a rapid escalation in the demand of bioprocess technology. The companies like Sartorius, Merck KGaA have shifted their focus of production of new drugs, for example, the drugs used for the treatment of COVID-19 virus, to the Single-Use Technologies. The recent upsurge of SUTs have led to creation of many opportunities for the companies supplies these products.
Avail customized purchase options for your needs
Bioprocess technology market: Key players
Some of the major players in the bioprocess technology market are as follows:
- MilliporeSigma (Merck KGaA)
- Danher Life Sciences
- GE Healthcare (General Electric)
- Fujifilm Healthcare
- Lonza- Pharma & biotech
- CPC (Colder Products Co.)
- Thermo Fisher Scientific
- Sartorius Stedim Biotech
- Asahi Kasei Medical
- Boehringer Ingelheim
- Solesis Medical (Fenner PLC)
- Dickinson and Company
- Bio-Rad Laboratories
- Charles River laboratories.
GE Healthcare has completed the acquisition of Puridify, a bioprocessing start up that is developing nanofiber-based platform purification technology for biopharmaceutical production. Puridify's FibroSelect technology complements the bead resins and chromatography membranes used today in downstream bioprocessing, and is expected to achieve faster mass transfer, scalability, and ease of use.
An Adaptive Approach to Modern-day Research Needs
Bioprocess Technology Market Report Highlights:
- Detailed overview of parent market.
- Changing market dynamics in the industry.
- In-depth market segmentation.
- Historical, current and projected market size in terms of volume and value.
- Recent industry trends and developments.
- Competitive landscape.
- Strategies of key players and products offered.
- Potential and niche segments, geographical regions exhibiting promising growth.
- A neutral perspective on market performance.
- Must-have information for market players to sustain and enhance their market footprint.
Have a report related query? Speak to us directly
Based on Type:
- Cell Culture
- Cell Expansion
- Flow Cytometry
- Cell Line Development
- Virus Infiltration
Based on application:
- Specialty Products
- Industry Chemicals
- Environment Management Aid
Based on End-User
- Research labs
- Medical Institutions
Based on Region:
- North America
- US & Canada
- Latin America
- East Asia
- South Korea
- South Asia
- New Zealand
- Middle East and Africa
- GCC Countries
- North Africa
- South Africa
- Other Africa
- North America
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.